ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Colloids (Blood Plasma) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-889
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Colloids Blood Plasma Market Insights and Forecast to 2027
BUY CHAPTERS

Colloids (Blood Plasma) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-889
Report
March 2024
Pages:165
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Behring
Baxter
Grifols S A
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
Hospira
Axa parenterals
Fresenius Kabi(China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Octapharma
Octapharma AG
Kedrion S p A

Colloids (Blood Plasma) - Market Size

The global market for Colloids (Blood Plasma) was estimated to be worth US$ 406.7 million in 2023 and is forecast to a readjusted size of US$ 339.9 million by 2030 with a CAGR of -2.5% during the forecast period 2024-2030

Colloids (Blood Plasma) - Market

Colloids (Blood Plasma) - Market

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Colloids (Blood Plasma) by region & country, by Type, and by Application.
The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).
Market Segmentation

Scope of Colloids (Blood Plasma) - Market Report

Report Metric Details
Report Name Colloids (Blood Plasma) - Market
Forecasted market size in 2030 US$ 339.9 million
CAGR 33
Forecasted years 2024 - 2030
Segment by Type:
  • Natural Type Colloids (Blood Plasma)
  • Synthetic Type Colloids (Blood Plasma)
Segment by Application
  • Extensive Burns
  • Massive Blood or Plasma Loss
  • Hypovolemic Shock
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi (China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Colloids (Blood Plasma) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Colloids (Blood Plasma) - Market size in 2030?

Ans: The Colloids (Blood Plasma) - Market size in 2030 will be US$ 339.9 million.

What is the Colloids (Blood Plasma) - Market share by region?

Ans: Europe is follower, accounting for about 28% market share.

What is the market share of major companies in Colloids (Blood Plasma) - Market?

Ans: Top 3 companies occupied about 46% market share.

Who are the main players in the Colloids (Blood Plasma) - Market report?

Ans: The main players in the Colloids (Blood Plasma) - Market are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi (China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm

What are the Application segmentation covered in the Colloids (Blood Plasma) - Market report?

Ans: The Applications covered in the Colloids (Blood Plasma) - Market report are Extensive Burns, Massive Blood or Plasma Loss, Hypovolemic Shock, Others

What are the Type segmentation covered in the Colloids (Blood Plasma) - Market report?

Ans: The Types covered in the Colloids (Blood Plasma) - Market report are Natural Type Colloids (Blood Plasma), Synthetic Type Colloids (Blood Plasma)

1 Market Overview
1.1 Colloids (Blood Plasma) Product Introduction
1.2 Global Colloids (Blood Plasma) Market Size Forecast
1.2.1 Global Colloids (Blood Plasma) Sales Value (2019-2030)
1.2.2 Global Colloids (Blood Plasma) Sales Volume (2019-2030)
1.2.3 Global Colloids (Blood Plasma) Sales Price (2019-2030)
1.3 Colloids (Blood Plasma) Market Trends & Drivers
1.3.1 Colloids (Blood Plasma) Industry Trends
1.3.2 Colloids (Blood Plasma) Market Drivers & Opportunity
1.3.3 Colloids (Blood Plasma) Market Challenges
1.3.4 Colloids (Blood Plasma) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Colloids (Blood Plasma) Players Revenue Ranking (2023)
2.2 Global Colloids (Blood Plasma) Revenue by Company (2019-2024)
2.3 Global Colloids (Blood Plasma) Players Sales Volume Ranking (2023)
2.4 Global Colloids (Blood Plasma) Sales Volume by Company Players (2019-2024)
2.5 Global Colloids (Blood Plasma) Average Price by Company (2019-2024)
2.6 Key Manufacturers Colloids (Blood Plasma) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Colloids (Blood Plasma) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Colloids (Blood Plasma)
2.9 Colloids (Blood Plasma) Market Competitive Analysis
2.9.1 Colloids (Blood Plasma) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Colloids (Blood Plasma) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Natural Type Colloids (Blood Plasma)
3.1.2 Synthetic Type Colloids (Blood Plasma)
3.2 Global Colloids (Blood Plasma) Sales Value by Type
3.2.1 Global Colloids (Blood Plasma) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Colloids (Blood Plasma) Sales Value, by Type (2019-2030)
3.2.3 Global Colloids (Blood Plasma) Sales Value, by Type (%) (2019-2030)
3.3 Global Colloids (Blood Plasma) Sales Volume by Type
3.3.1 Global Colloids (Blood Plasma) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Colloids (Blood Plasma) Sales Volume, by Type (2019-2030)
3.3.3 Global Colloids (Blood Plasma) Sales Volume, by Type (%) (2019-2030)
3.4 Global Colloids (Blood Plasma) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Extensive Burns
4.1.2 Massive Blood or Plasma Loss
4.1.3 Hypovolemic Shock
4.1.4 Others
4.2 Global Colloids (Blood Plasma) Sales Value by Application
4.2.1 Global Colloids (Blood Plasma) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Colloids (Blood Plasma) Sales Value, by Application (2019-2030)
4.2.3 Global Colloids (Blood Plasma) Sales Value, by Application (%) (2019-2030)
4.3 Global Colloids (Blood Plasma) Sales Volume by Application
4.3.1 Global Colloids (Blood Plasma) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Colloids (Blood Plasma) Sales Volume, by Application (2019-2030)
4.3.3 Global Colloids (Blood Plasma) Sales Volume, by Application (%) (2019-2030)
4.4 Global Colloids (Blood Plasma) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Colloids (Blood Plasma) Sales Value by Region
5.1.1 Global Colloids (Blood Plasma) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Colloids (Blood Plasma) Sales Value by Region (2019-2024)
5.1.3 Global Colloids (Blood Plasma) Sales Value by Region (2025-2030)
5.1.4 Global Colloids (Blood Plasma) Sales Value by Region (%), (2019-2030)
5.2 Global Colloids (Blood Plasma) Sales Volume by Region
5.2.1 Global Colloids (Blood Plasma) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Colloids (Blood Plasma) Sales Volume by Region (2019-2024)
5.2.3 Global Colloids (Blood Plasma) Sales Volume by Region (2025-2030)
5.2.4 Global Colloids (Blood Plasma) Sales Volume by Region (%), (2019-2030)
5.3 Global Colloids (Blood Plasma) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Colloids (Blood Plasma) Sales Value, 2019-2030
5.4.2 North America Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Colloids (Blood Plasma) Sales Value, 2019-2030
5.5.2 Europe Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Colloids (Blood Plasma) Sales Value, 2019-2030
5.6.2 Asia Pacific Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Colloids (Blood Plasma) Sales Value, 2019-2030
5.7.2 South America Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Colloids (Blood Plasma) Sales Value, 2019-2030
5.8.2 Middle East & Africa Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Colloids (Blood Plasma) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Colloids (Blood Plasma) Sales Value
6.2.1 Key Countries/Regions Colloids (Blood Plasma) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Colloids (Blood Plasma) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Colloids (Blood Plasma) Sales Value, 2019-2030
6.3.2 United States Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Colloids (Blood Plasma) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Colloids (Blood Plasma) Sales Value, 2019-2030
6.4.2 Europe Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Colloids (Blood Plasma) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Colloids (Blood Plasma) Sales Value, 2019-2030
6.5.2 China Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Colloids (Blood Plasma) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Colloids (Blood Plasma) Sales Value, 2019-2030
6.6.2 Japan Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Colloids (Blood Plasma) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Colloids (Blood Plasma) Sales Value, 2019-2030
6.7.2 South Korea Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Colloids (Blood Plasma) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Colloids (Blood Plasma) Sales Value, 2019-2030
6.8.2 Southeast Asia Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Colloids (Blood Plasma) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Colloids (Blood Plasma) Sales Value, 2019-2030
6.9.2 India Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Colloids (Blood Plasma) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CSL Behring
7.1.1 CSL Behring Company Information
7.1.2 CSL Behring Introduction and Business Overview
7.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 CSL Behring Colloids (Blood Plasma) Product Offerings
7.1.5 CSL Behring Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Colloids (Blood Plasma) Product Offerings
7.2.5 Baxter Recent Development
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Introduction and Business Overview
7.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Grifols Colloids (Blood Plasma) Product Offerings
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Octapharma Colloids (Blood Plasma) Product Offerings
7.4.5 Octapharma Recent Development
7.5 Kedrion
7.5.1 Kedrion Company Information
7.5.2 Kedrion Introduction and Business Overview
7.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Kedrion Colloids (Blood Plasma) Product Offerings
7.5.5 Kedrion Recent Development
7.6 Shanghai Raas
7.6.1 Shanghai Raas Company Information
7.6.2 Shanghai Raas Introduction and Business Overview
7.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Shanghai Raas Colloids (Blood Plasma) Product Offerings
7.6.5 Shanghai Raas Recent Development
7.7 CTBB
7.7.1 CTBB Company Information
7.7.2 CTBB Introduction and Business Overview
7.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 CTBB Colloids (Blood Plasma) Product Offerings
7.7.5 CTBB Recent Development
7.8 Hualan Bio
7.8.1 Hualan Bio Company Information
7.8.2 Hualan Bio Introduction and Business Overview
7.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hualan Bio Colloids (Blood Plasma) Product Offerings
7.8.5 Hualan Bio Recent Development
7.9 Rongsheng Pharmaceutical
7.9.1 Rongsheng Pharmaceutical Company Information
7.9.2 Rongsheng Pharmaceutical Introduction and Business Overview
7.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Offerings
7.9.5 Rongsheng Pharmaceutical Recent Development
7.10 Boya Rongsheng
7.10.1 Boya Rongsheng Company Information
7.10.2 Boya Rongsheng Introduction and Business Overview
7.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Offerings
7.10.5 Boya Rongsheng Recent Development
7.11 B. Braun Medical
7.11.1 B. Braun Medical Company Information
7.11.2 B. Braun Medical Introduction and Business Overview
7.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 B. Braun Medical Colloids (Blood Plasma) Product Offerings
7.11.5 B. Braun Medical Recent Development
7.12 Fresenius Kabi
7.12.1 Fresenius Kabi Company Information
7.12.2 Fresenius Kabi Introduction and Business Overview
7.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Offerings
7.12.5 Fresenius Kabi Recent Development
7.13 HOSPIRA
7.13.1 HOSPIRA Company Information
7.13.2 HOSPIRA Introduction and Business Overview
7.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 HOSPIRA Colloids (Blood Plasma) Product Offerings
7.13.5 HOSPIRA Recent Development
7.14 Axa parenterals
7.14.1 Axa parenterals Company Information
7.14.2 Axa parenterals Introduction and Business Overview
7.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Axa parenterals Colloids (Blood Plasma) Product Offerings
7.14.5 Axa parenterals Recent Development
7.15 Fresenius Kabi (China)
7.15.1 Fresenius Kabi (China) Company Information
7.15.2 Fresenius Kabi (China) Introduction and Business Overview
7.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Offerings
7.15.5 Fresenius Kabi (China) Recent Development
7.16 CR Double-Crane
7.16.1 CR Double-Crane Company Information
7.16.2 CR Double-Crane Introduction and Business Overview
7.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 CR Double-Crane Colloids (Blood Plasma) Product Offerings
7.16.5 CR Double-Crane Recent Development
7.17 Kelun Group
7.17.1 Kelun Group Company Information
7.17.2 Kelun Group Introduction and Business Overview
7.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Kelun Group Colloids (Blood Plasma) Product Offerings
7.17.5 Kelun Group Recent Development
7.18 Shandong Qidu Pharmaceutical
7.18.1 Shandong Qidu Pharmaceutical Company Information
7.18.2 Shandong Qidu Pharmaceutical Introduction and Business Overview
7.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Offerings
7.18.5 Shandong Qidu Pharmaceutical Recent Development
7.19 Shandong Hualu Pharmaceutical
7.19.1 Shandong Hualu Pharmaceutical Company Information
7.19.2 Shandong Hualu Pharmaceutical Introduction and Business Overview
7.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Offerings
7.19.5 Shandong Hualu Pharmaceutical Recent Development
7.20 Minsheng Pharma
7.20.1 Minsheng Pharma Company Information
7.20.2 Minsheng Pharma Introduction and Business Overview
7.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Offerings
7.20.5 Minsheng Pharma Recent Development
7.21 Kanglepharm
7.21.1 Kanglepharm Company Information
7.21.2 Kanglepharm Introduction and Business Overview
7.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Kanglepharm Colloids (Blood Plasma) Product Offerings
7.21.5 Kanglepharm Recent Development
8 Industry Chain Analysis
8.1 Colloids (Blood Plasma) Industrial Chain
8.2 Colloids (Blood Plasma) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Colloids (Blood Plasma) Sales Model
8.5.2 Sales Channel
8.5.3 Colloids (Blood Plasma) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
CSL Behring
Baxter
Grifols S A
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
Hospira
Axa parenterals
Fresenius Kabi(China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Octapharma
Octapharma AG
Kedrion S p A
List of Tables
    Table 1. Colloids (Blood Plasma) Market Trends
    Table 2. Colloids (Blood Plasma) Market Drivers & Opportunity
    Table 3. Colloids (Blood Plasma) Market Challenges
    Table 4. Colloids (Blood Plasma) Market Restraints
    Table 5. Global Colloids (Blood Plasma) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Colloids (Blood Plasma) Revenue Market Share by Company (2019-2024)
    Table 7. Global Colloids (Blood Plasma) Sales Volume by Company (2019-2024) & (MT)
    Table 8. Global Colloids (Blood Plasma) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Colloids (Blood Plasma) Price by Company (2019-2024) & (USD/Kg)
    Table 10. Key Manufacturers Colloids (Blood Plasma) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Colloids (Blood Plasma) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Colloids (Blood Plasma)
    Table 13. Global Colloids (Blood Plasma) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Colloids (Blood Plasma) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Colloids (Blood Plasma) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Colloids (Blood Plasma) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Colloids (Blood Plasma) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Colloids (Blood Plasma) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Colloids (Blood Plasma) Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)
    Table 22. Global Colloids (Blood Plasma) Sales Volume by Type (2019-2024) & (MT)
    Table 23. Global Colloids (Blood Plasma) Sales Volume by Type (2025-2030) & (MT)
    Table 24. Global Colloids (Blood Plasma) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Colloids (Blood Plasma) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Colloids (Blood Plasma) Price by Type (2019-2024) & (USD/Kg)
    Table 27. Global Colloids (Blood Plasma) Price by Type (2025-2030) & (USD/Kg)
    Table 28. Global Colloids (Blood Plasma) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Colloids (Blood Plasma) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Colloids (Blood Plasma) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Colloids (Blood Plasma) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Colloids (Blood Plasma) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Colloids (Blood Plasma) Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)
    Table 34. Global Colloids (Blood Plasma) Sales Volume by Application (2019-2024) & (MT)
    Table 35. Global Colloids (Blood Plasma) Sales Volume by Application (2025-2030) & (MT)
    Table 36. Global Colloids (Blood Plasma) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Colloids (Blood Plasma) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Colloids (Blood Plasma) Price by Application (2019-2024) & (USD/Kg)
    Table 39. Global Colloids (Blood Plasma) Price by Application (2025-2030) & (USD/Kg)
    Table 40. Global Colloids (Blood Plasma) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Colloids (Blood Plasma) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Colloids (Blood Plasma) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Colloids (Blood Plasma) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Colloids (Blood Plasma) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Colloids (Blood Plasma) Sales Volume by Region (MT): 2019 VS 2023 VS 2030
    Table 46. Global Colloids (Blood Plasma) Sales Volume by Region (2019-2024) & (MT)
    Table 47. Global Colloids (Blood Plasma) Sales Volume by Region (2025-2030) & (MT)
    Table 48. Global Colloids (Blood Plasma) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Colloids (Blood Plasma) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Colloids (Blood Plasma) Average Price by Region (2019-2024) & (USD/Kg)
    Table 51. Global Colloids (Blood Plasma) Average Price by Region (2025-2030) & (USD/Kg)
    Table 52. Key Countries/Regions Colloids (Blood Plasma) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Colloids (Blood Plasma) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Colloids (Blood Plasma) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Colloids (Blood Plasma) Sales Volume, (2019-2024) & (MT)
    Table 56. Key Countries/Regions Colloids (Blood Plasma) Sales Volume, (2025-2030) & (MT)
    Table 57. CSL Behring Company Information
    Table 58. CSL Behring Introduction and Business Overview
    Table 59. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 60. CSL Behring Colloids (Blood Plasma) Product Offerings
    Table 61. CSL Behring Recent Development
    Table 62. Baxter Company Information
    Table 63. Baxter Introduction and Business Overview
    Table 64. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 65. Baxter Colloids (Blood Plasma) Product Offerings
    Table 66. Baxter Recent Development
    Table 67. Grifols Company Information
    Table 68. Grifols Introduction and Business Overview
    Table 69. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 70. Grifols Colloids (Blood Plasma) Product Offerings
    Table 71. Grifols Recent Development
    Table 72. Octapharma Company Information
    Table 73. Octapharma Introduction and Business Overview
    Table 74. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 75. Octapharma Colloids (Blood Plasma) Product Offerings
    Table 76. Octapharma Recent Development
    Table 77. Kedrion Company Information
    Table 78. Kedrion Introduction and Business Overview
    Table 79. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 80. Kedrion Colloids (Blood Plasma) Product Offerings
    Table 81. Kedrion Recent Development
    Table 82. Shanghai Raas Company Information
    Table 83. Shanghai Raas Introduction and Business Overview
    Table 84. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 85. Shanghai Raas Colloids (Blood Plasma) Product Offerings
    Table 86. Shanghai Raas Recent Development
    Table 87. CTBB Company Information
    Table 88. CTBB Introduction and Business Overview
    Table 89. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 90. CTBB Colloids (Blood Plasma) Product Offerings
    Table 91. CTBB Recent Development
    Table 92. Hualan Bio Company Information
    Table 93. Hualan Bio Introduction and Business Overview
    Table 94. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 95. Hualan Bio Colloids (Blood Plasma) Product Offerings
    Table 96. Hualan Bio Recent Development
    Table 97. Rongsheng Pharmaceutical Company Information
    Table 98. Rongsheng Pharmaceutical Introduction and Business Overview
    Table 99. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 100. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Offerings
    Table 101. Rongsheng Pharmaceutical Recent Development
    Table 102. Boya Rongsheng Company Information
    Table 103. Boya Rongsheng Introduction and Business Overview
    Table 104. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 105. Boya Rongsheng Colloids (Blood Plasma) Product Offerings
    Table 106. Boya Rongsheng Recent Development
    Table 107. B. Braun Medical Company Information
    Table 108. B. Braun Medical Introduction and Business Overview
    Table 109. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 110. B. Braun Medical Colloids (Blood Plasma) Product Offerings
    Table 111. B. Braun Medical Recent Development
    Table 112. Fresenius Kabi Company Information
    Table 113. Fresenius Kabi Introduction and Business Overview
    Table 114. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 115. Fresenius Kabi Colloids (Blood Plasma) Product Offerings
    Table 116. Fresenius Kabi Recent Development
    Table 117. HOSPIRA Company Information
    Table 118. HOSPIRA Introduction and Business Overview
    Table 119. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 120. HOSPIRA Colloids (Blood Plasma) Product Offerings
    Table 121. HOSPIRA Recent Development
    Table 122. Axa parenterals Company Information
    Table 123. Axa parenterals Introduction and Business Overview
    Table 124. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 125. Axa parenterals Colloids (Blood Plasma) Product Offerings
    Table 126. Axa parenterals Recent Development
    Table 127. Fresenius Kabi (China) Company Information
    Table 128. Fresenius Kabi (China) Introduction and Business Overview
    Table 129. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 130. Fresenius Kabi (China) Colloids (Blood Plasma) Product Offerings
    Table 131. Fresenius Kabi (China) Recent Development
    Table 132. CR Double-Crane Company Information
    Table 133. CR Double-Crane Introduction and Business Overview
    Table 134. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 135. CR Double-Crane Colloids (Blood Plasma) Product Offerings
    Table 136. CR Double-Crane Recent Development
    Table 137. Kelun Group Company Information
    Table 138. Kelun Group Introduction and Business Overview
    Table 139. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 140. Kelun Group Colloids (Blood Plasma) Product Offerings
    Table 141. Kelun Group Recent Development
    Table 142. Shandong Qidu Pharmaceutical Company Information
    Table 143. Shandong Qidu Pharmaceutical Introduction and Business Overview
    Table 144. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 145. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Offerings
    Table 146. Shandong Qidu Pharmaceutical Recent Development
    Table 147. Shandong Hualu Pharmaceutical Company Information
    Table 148. Shandong Hualu Pharmaceutical Introduction and Business Overview
    Table 149. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 150. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Offerings
    Table 151. Shandong Hualu Pharmaceutical Recent Development
    Table 152. Minsheng Pharma Company Information
    Table 153. Minsheng Pharma Introduction and Business Overview
    Table 154. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 155. Minsheng Pharma Colloids (Blood Plasma) Product Offerings
    Table 156. Minsheng Pharma Recent Development
    Table 157. Kanglepharm Company Information
    Table 158. Kanglepharm Introduction and Business Overview
    Table 159. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 160. Kanglepharm Colloids (Blood Plasma) Product Offerings
    Table 161. Kanglepharm Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Colloids (Blood Plasma) Downstream Customers
    Table 165. Colloids (Blood Plasma) Distributors List
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Colloids (Blood Plasma) Product Picture
    Figure 2. Global Colloids (Blood Plasma) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Colloids (Blood Plasma) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Colloids (Blood Plasma) Sales Volume (2019-2030) & (MT)
    Figure 5. Global Colloids (Blood Plasma) Sales Price (2019-2030) & (USD/Kg)
    Figure 6. Colloids (Blood Plasma) Report Years Considered
    Figure 7. Global Colloids (Blood Plasma) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Colloids (Blood Plasma) Players Sales Volume Ranking (2023) & (MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Colloids (Blood Plasma) Revenue in 2023
    Figure 10. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Natural Type Colloids (Blood Plasma) Picture
    Figure 12. Synthetic Type Colloids (Blood Plasma) Picture
    Figure 13. Global Colloids (Blood Plasma) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Colloids (Blood Plasma) Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Colloids (Blood Plasma) Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
    Figure 16. Global Colloids (Blood Plasma) Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Colloids (Blood Plasma) Price by Type (2019-2030) & (USD/Kg)
    Figure 18. Product Picture of Extensive Burns
    Figure 19. Product Picture of Massive Blood or Plasma Loss
    Figure 20. Product Picture of Hypovolemic Shock
    Figure 21. Product Picture of Others
    Figure 22. Global Colloids (Blood Plasma) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Colloids (Blood Plasma) Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Colloids (Blood Plasma) Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
    Figure 25. Global Colloids (Blood Plasma) Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Colloids (Blood Plasma) Price by Application (2019-2030) & (USD/Kg)
    Figure 27. North America Colloids (Blood Plasma) Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Colloids (Blood Plasma) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Colloids (Blood Plasma) Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Colloids (Blood Plasma) Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Colloids (Blood Plasma) Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Colloids (Blood Plasma) Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Colloids (Blood Plasma) Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Colloids (Blood Plasma) Sales Volume (%), (2019-2030)
    Figure 39. United States Colloids (Blood Plasma) Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Colloids (Blood Plasma) Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Colloids (Blood Plasma) Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Colloids (Blood Plasma) Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Colloids (Blood Plasma) Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Colloids (Blood Plasma) Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Colloids (Blood Plasma) Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Colloids (Blood Plasma) Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Colloids (Blood Plasma) Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Colloids (Blood Plasma) Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Colloids (Blood Plasma) Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Colloids (Blood Plasma) Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Colloids (Blood Plasma) Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Colloids (Blood Plasma) Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Colloids (Blood Plasma) Sales Value by Application (%), 2023 VS 2030
    Figure 60. Colloids (Blood Plasma) Industrial Chain
    Figure 61. Colloids (Blood Plasma) Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions